DEUTSCHE BANK AG\ - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$398,000
+41.6%
21,139
-12.1%
0.00%
Q2 2019$281,000
+6.0%
24,062
+23.5%
0.00%
Q1 2019$265,000
-90.4%
19,476
-92.8%
0.00%
-100.0%
Q4 2018$2,761,000
-69.5%
269,509
-50.4%
0.00%
-33.3%
Q3 2018$9,045,000
-27.0%
543,366
-30.7%
0.00%
-25.0%
Q2 2018$12,388,000
+87.2%
784,149
+50.4%
0.00%
+33.3%
Q1 2018$6,619,000
+89.6%
521,308
+70.9%
0.00%
+50.0%
Q4 2017$3,491,000
+17.2%
304,972
+25.3%
0.00%0.0%
Q3 2017$2,979,000
+56.4%
243,361
+46.1%
0.00%
+100.0%
Q2 2017$1,905,000
-24.7%
166,583
+36.8%
0.00%
-50.0%
Q1 2017$2,530,000
-23.2%
121,770
-23.2%
0.00%
-33.3%
Q4 2016$3,294,000
-45.3%
158,530
-13.8%
0.00%
-25.0%
Q3 2016$6,022,000
+35.0%
183,825
+2.9%
0.00%
+33.3%
Q2 2016$4,460,000
-41.1%
178,713
-42.2%
0.00%
-50.0%
Q1 2016$7,569,000
+452.9%
309,165
+644.9%
0.01%
+500.0%
Q4 2015$1,369,000
-39.8%
41,506
-40.2%
0.00%
-50.0%
Q3 2015$2,273,000
-51.7%
69,455
-21.9%
0.00%
-33.3%
Q2 2015$4,708,000
+788.3%
88,953
+382.5%
0.00%
Q1 2015$530,00018,437
+54126.5%
0.00%
Q4 2014$0
-100.0%
34
-99.7%
0.00%
Q3 2014$128,000
-20.5%
10,244
+26.8%
0.00%
Q2 2014$161,0008,0800.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders